197 related articles for article (PubMed ID: 34592041)
21. Disparate effects of the calcium-channel blockers, nifedipine and verapamil, on alpha 2-adrenergic receptors and thromboxane A2-induced aggregation of human platelets.
Johnson GJ; Leis LA; Francis GS
Circulation; 1986 Apr; 73(4):847-54. PubMed ID: 3004784
[TBL] [Abstract][Full Text] [Related]
22. Relative effects of flurbiprofen on platelet 12-hydroxy-eicosatetraenoic acid and thromboxane A2 production: influence on collagen-induced platelet aggregation and adhesion.
Van Ryan-McKenna J; Buchanan MR
Prostaglandins Leukot Essent Fatty Acids; 1989 Jun; 36(3):171-4. PubMed ID: 2780761
[TBL] [Abstract][Full Text] [Related]
23. Platelet function in Watanabe heritable hyperlipidemic rabbits. Decreased sensitivity to thromboxane A2.
Gross PL; Rand ML; Barrow DV; Packham MA
Arterioscler Thromb; 1991; 11(3):610-6. PubMed ID: 2029501
[TBL] [Abstract][Full Text] [Related]
24. Thromboxane A2-mediated shape change: independent of Gq-phospholipase C--Ca2+ pathway in rabbit platelets.
Ohkubo S; Nakahata N; Ohizumi Y
Br J Pharmacol; 1996 Mar; 117(6):1095-104. PubMed ID: 8882602
[TBL] [Abstract][Full Text] [Related]
25. Thromboxane A2/prostaglandin endoperoxide (TXA2/PG-END) receptor binding properties in human platelets of ridogrel, a combined TXA2 synthase inhibitor--TXA2/PG-END receptor antagonist.
Heylen L; De Clerck F; Somers Y; Leysen JE
Blood Coagul Fibrinolysis; 1991 Oct; 2(5):617-21. PubMed ID: 1838285
[TBL] [Abstract][Full Text] [Related]
26. Thromboxane A2 causes feedback amplification involving extensive thromboxane A2 formation on close contact of human platelets in media with a low concentration of ionized calcium.
Packham MA; Kinlough-Rathbone RL; Mustard JF
Blood; 1987 Sep; 70(3):647-51. PubMed ID: 3620698
[TBL] [Abstract][Full Text] [Related]
27. The roles of LAT in platelet signaling induced by collagen, TxA2, or ADP.
Cho MJ; Pestina TI; Steward SA; Jackson CW; Kent Gartner T
Biochem Biophys Res Commun; 2002 Apr; 292(4):916-21. PubMed ID: 11944902
[TBL] [Abstract][Full Text] [Related]
28. Lipopolysaccharide treatment reduces rat platelet aggregation independent of intracellular reactive-oxygen species generation.
Lopes-Pires ME; Casarin AL; Pereira-Cunha FG; Lorand-Metze I; Antunes E; Marcondes S
Platelets; 2012; 23(3):195-201. PubMed ID: 21806496
[TBL] [Abstract][Full Text] [Related]
29. Reversal of thromboxane A2/prostaglandin H2 and ADP-induced calcium release in intact platelets.
Brace LD; Venton DL; Le Breton GC
Am J Physiol; 1985 Jul; 249(1 Pt 2):H8-13. PubMed ID: 2409821
[TBL] [Abstract][Full Text] [Related]
30. cAMP- and cGMP-elevating agents inhibit GPIbα-mediated aggregation but not GPIbα-stimulated Syk activation in human platelets.
Makhoul S; Trabold K; Gambaryan S; Tenzer S; Pillitteri D; Walter U; Jurk K
Cell Commun Signal; 2019 Sep; 17(1):122. PubMed ID: 31519182
[TBL] [Abstract][Full Text] [Related]
31. Subnormal platelet response to thromboxane A2 in a patient with chronic myeloid leukaemia.
Okuma M; Takayama H; Uchino H
Br J Haematol; 1982 Jul; 51(3):469-77. PubMed ID: 6809032
[TBL] [Abstract][Full Text] [Related]
32. Impaired platelet response to thromboxane-A2 and defective calcium mobilization in a patient with a bleeding disorder.
Lages B; Malmsten C; Weiss HJ; Samuelsson B
Blood; 1981 Mar; 57(3):545-52. PubMed ID: 7459434
[TBL] [Abstract][Full Text] [Related]
33. Two phasic generation of thromboxane A2 by the action of collagen on rat platelets.
Hanasaki K; Nakano T; Arita H
Thromb Res; 1987 May; 46(3):425-36. PubMed ID: 2955543
[TBL] [Abstract][Full Text] [Related]
34. Protein disulfide isomerase regulation by nitric oxide maintains vascular quiescence and controls thrombus formation.
Bekendam RH; Iyu D; Passam F; Stopa JD; De Ceunynck K; Muse O; Bendapudi PK; Garnier CL; Gopal S; Crescence L; Chiu J; Furie B; Panicot-Dubois L; Hogg PJ; Dubois C; Flaumenhaft R
J Thromb Haemost; 2018 Nov; 16(11):2322-2335. PubMed ID: 30207066
[TBL] [Abstract][Full Text] [Related]
35. The response to thromboxane A2 analogues in human platelets. Discrimination of two binding sites linked to distinct effector systems.
Takahara K; Murray R; FitzGerald GA; Fitzgerald DJ
J Biol Chem; 1990 Apr; 265(12):6836-44. PubMed ID: 2139029
[TBL] [Abstract][Full Text] [Related]
36. Calcium-Dependent Src Phosphorylation and Reactive Oxygen Species Generation Are Implicated in the Activation of Human Platelet Induced by Thromboxane A2 Analogs.
Minuz P; Meneguzzi A; Fumagalli L; Degan M; Calabria S; Ferraro R; Ricci M; Veneri D; Berton G
Front Pharmacol; 2018; 9():1081. PubMed ID: 30319416
[TBL] [Abstract][Full Text] [Related]
37. SDF-1α is a novel autocrine activator of platelets operating through its receptor CXCR4.
Walsh TG; Harper MT; Poole AW
Cell Signal; 2015 Jan; 27(1):37-46. PubMed ID: 25283599
[TBL] [Abstract][Full Text] [Related]
38. Daidzein Inhibits Human Platelet Activation by Downregulating Thromboxane A
Hong HJ; Nam GS; Nam KS
Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569361
[TBL] [Abstract][Full Text] [Related]
39. Bacitracin reveals a role for multiple thiol isomerases in platelet function.
Robinson A; O'Neill S; Kiernan A; O'Donoghue N; Moran N
Br J Haematol; 2006 Feb; 132(3):339-48. PubMed ID: 16409299
[TBL] [Abstract][Full Text] [Related]
40. Antiplatelet effect of catechol is related to inhibition of cyclooxygenase, reactive oxygen species, ERK/p38 signaling and thromboxane A2 production.
Chang MC; Chang HH; Wang TM; Chan CP; Lin BR; Yeung SY; Yeh CY; Cheng RH; Jeng JH
PLoS One; 2014; 9(8):e104310. PubMed ID: 25122505
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
